Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Clear-Cell Renal Cell Carcinoma”

916 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 916 results

Not applicableStudy completedNCT01173445
What this trial is testing

Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas 19
Testing effectiveness (Phase 2)UnknownNCT00080977
What this trial is testing

High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2

Who this might be right for
Kidney Cancer
Blumenthal Cancer Center at Carolinas Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00485563
What this trial is testing

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Endocyte 12
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT01061411
What this trial is testing

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 16
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT00444314
What this trial is testing

Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
CASI Pharmaceuticals, Inc. 82
Testing effectiveness (Phase 2)UnknownNCT00003181
What this trial is testing

Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Hope Cancer Institute, Inc. 35
Early research (Phase 1)Looking for participantsNCT07300241
What this trial is testing

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell CarcinomaRCC+6 more
Neomorph, Inc 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03141177
What this trial is testing

Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 701
Not applicableWithdrawnNCT00538772
What this trial is testing

An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy

Who this might be right for
Carcinoma, Renal Cell
Kim Chi
Testing effectiveness (Phase 2)Study completedNCT01108445
What this trial is testing

Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Non-clear Cell Renal Cell Carcinoma
Duke University 131
Not applicableStudy completedNCT02627144
What this trial is testing

Bevacizumab in Metastatic Renal Cancer

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 365
Testing effectiveness (Phase 2)Study completedNCT00467025
What this trial is testing

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

Who this might be right for
Advanced Renal Cell Carcinoma
Amgen 152
Not applicableLooking for participantsNCT06391099
What this trial is testing

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell Carcinoma+1 more
Ohio State University Comprehensive Cancer Center 60
Early research (Phase 1)Study completedNCT01525017
What this trial is testing

A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Mendus 12
Testing effectiveness (Phase 2)UnknownNCT00002847
What this trial is testing

Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Blumenthal Cancer Center at Carolinas Medical Center 14
Testing effectiveness (Phase 2)Temporarily pausedNCT06059014
What this trial is testing

Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients with Metastatic Clear Cell Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Centre Leon Berard 48
Testing effectiveness (Phase 2)Study completedNCT01835158
What this trial is testing

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 157
Very early researchLooking for participantsNCT06586658
What this trial is testing

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

Who this might be right for
Renal Cell Carcinoma
Shanghai Changzheng Hospital 9
Load More Results